Effects of the luteinising hormone-releasing hormone (LH-RH) agonist leuprolide on adenylyl cyclase regulation through G-protein coupled receptors in rat ventral prostate

Author： Salvador A.   Garca-Paramio M.P.   Sanchez-Chapado M.   Carmena M.J.   Prieto J.C.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.5, 2001-03, pp. : 641-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists

By Limonta P.   Pratesi G.   Moretti R.M.   Montagnani Marelli M.   Motta M.   Dondi D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1134-1135

Elsevier

Access to resources Recommend Favorite

Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer

By Ishizuka Osamu  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 524-530

Springer Publishing Company

Access to resources Recommend Favorite

A Randomised Study to Compare the Effect of the Luteinising Hormone Releasing Hormone (LHRH) Analogue Goserelin With or Without Tamoxifen in Pre- and Perimenopausal Patients With Advanced Breast Cancer

By Jonat W.   Kaufmann M.   Blamey R.W.   Howell A.   Collins J.P.   Coates A.   Eiermann W.   Janicke F.   Njordenskold B.   Forbes J.F.   Kolvenbag G.J.C.M.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists RC-3940-II and RC-3950-II

By Jungwirth A.   Pinski J.   Galvan G.   Halmos G.   Szepeshazi K.   Cai R.Z.   Groot K.   Vadillo-Buenfil M.   Schally A.V.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1141-1148

Elsevier

Access to resources Recommend Favorite

Pharmacological Studies with Cetrorelix (SB-75), a Potent Antagonist of Luteinising Hormone-releasing Hormone

By Reissmann T.   Klenner T.   Deger W.   Hilgard P.   McGregor G.P.   Voigt K.   Engel J.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1574-1579

Elsevier

Access to resources Recommend Favorite